IREN
IREN Limited
There isn't enough reported data to score IREN yet.
PNNT
PennantPark Investment Corporation
PNNT's fundamentals are mixed, but it looks expensive: trading at 21x earnings, about three times its usual 7.5x. Analysts expect earnings to hold roughly steady.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
PNNT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
PNNT's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like PNNT.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
PNNT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3x | $0.49 | -85% |
| Forward | 5.6x | $3.25 | — |
| Fair | 7.5x | $1.19 | -63% |
| Expensive | 20x | $3.23 | -0.5% |
| Current | 21x | $3.25 | — |
Historical ranges are pointers, not guarantees.
PNNT's PE is in its expensive range at 21x. On analysts' estimates for next year's earnings, today's price would be 5.6x, in its fair range.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
PNNT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect PNNT's profitability to improve, with its earnings and revenue holding steady.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
PNNT has the stronger earnings trend. Trailing diluted EPS is down 347% for IREN versus PNNT down 91%.
PNNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.58 | +260% |
| Q2 2023 | -$1.23 | -337% |
| Q1 2023 | -$1.83 | -243% |
| Q4 2022 | -$1.85 | -203% |
| Q3 2022 | -$0.37 | -115% |
| Q2 2022 | $0.52 | -77% |
| Q1 2022 | $1.28 | -36% |
| Q4 2021 | $1.80 | +240% |
| Q3 2021 | $2.48 | +$2.72 |
PNNT has returned to profit: it earned $0.16 per share over the past year, after losing money the year before.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the stronger quarterly revenue trend. Revenue is down 5.1% for IREN versus down 185% for PNNT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
PNNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2022 | $12M | -73% |
| Q4 2021 | $40.3M | -48% |
| Q3 2021 | $31.8M | +66% |
| Q2 2021 | $39.9M | +70% |
| Q4 2020 | $77.4M | +162% |
| Q3 2020 | $19.2M | -13% |
PNNT's revenue has slid since its 2020 peak: −$27M last quarter, down 185% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | 28% | -58 points |
| Q4 2021 | 76% | -16 points |
| Q3 2021 | 79% | +28 points |
| Q2 2021 | 80% | +13 points |
| Q1 2021 | 86% | N/A |
| Q4 2020 | 92% | +26 points |
| Q3 2020 | 51% | +12 points |
| Q2 2020 | 68% | N/A |
PNNT's operating margin was 28% last quarter, down 58 points from the same quarter a year ago, near the bottom of its range since 2019.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
PNNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $50.1M | -2.7% |
| Q1 2026 | $36.4M | -74% |
| Q4 2025 | $134.5M | +618% |
| Q3 2025 | -$107.8M | -$103.1M |
| Q2 2025 | $51.5M | +$68.3M |
| Q1 2025 | $142.4M | +3247% |
| Q4 2024 | $18.7M | +$173.9M |
| Q3 2024 | -$4.7M | -104% |
PNNT has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
PNNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | +0.1% | +71.6K shares |
| 5 years | -2.6% | -1.7M shares |
| Available history | -2.6% | -1.7M shares |
PNNT has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2022 | $1.2M |
| Q2 2022 | $5M |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
PNNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 14.2x | High |
| Q1 2022 | 5.7x | High |
| Q4 2021 | 6.1x | High |
| Q3 2021 | 3.5x | Elevated |
| Q2 2021 | 3.2x | Elevated |
| Q1 2021 | 1.6x | Healthy |
| Q4 2020 | 2.4x | Moderate |
| Q3 2020 | 3.2x | Elevated |
PNNT's net debt is about 14 years of its operating earnings (EBITDA), up from 3.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like PNNT.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
PNNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 37.8 | Neutral |
PNNT's weekly RSI is 39 (neutral) and its Stochastic is 38 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
PNNT PE vs Financial Services Sector
| Metric | PNNT | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 13x | 61% above |
| PE % | 84 | 63 | 21 pts above |
PNNT is trading at 21x earnings, a 61% premium to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
PNNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.16 | 2.8% above |
| 20 week MA | $3.38 | 3.8% below |
| 50 week MA | $4.28 | 24% below |
| 100 week MA | $5.56 | 42% below |
| 200 week MA | $6.05 | 46% below |
PNNT has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 46% below its 200-week average.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
PNNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.60 | $4.52 | -32% |
| 2021 | $4.52 | $6.88 | +52% |
| 2022 | $6.88 | $5.65 | -18% |
| 2023 | $5.65 | $6.91 | +22% |
| 2024 | $6.91 | $6.99 | +1.2% |
| 2025 | $6.99 | $5.93 | -15% |
| 2026 YTD | $5.93 | $3.25 | -45% |
PNNT has the edge over IREN on returns for 2026, with the stronger performance.